ALT vs DHR · rev $20.0K vs P/E 39, rev $24.57B
Altimmune Inc (ALT) versus Danaher Corporation (DHR) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported DHR revenue for 2025-12-31 was $24.57B. Net income was $3.61B. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
ALT currently screens at market cap $527.0M. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Not investment advice. Open the ALT and DHR stock pages for the full models.
Not investment advice.